CIK 0001062822 · Non-accelerated filer<br>Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 760474169
- Phone
- 2818633000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-13 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +721,070 | 721,070 | ||
| 2025-02-13 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +480,710 | 480,710 | ||
| 2025-02-13 | Exton Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +2,264,690 | 2,264,690 | ||
| 2025-02-13 | Exton Michael Chief Executive Officer | Grant or award · Restricted Stock Units | +1,509,790 | 1,509,790 | ||
| 2025-01-02 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +230,000 | 230,000 | ||
| 2024-12-02 | Cheung Ivan Director | Grant or award · Stock Option (Right to Buy) | +186,685 | 186,685 | ||
| 2024-08-12 | Corrigan Brian SVP, Regulatory & QA | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2024-07-08 | WADE JEFFREY L President and COO | Grant or award · Stock Option (Right to Buy) | +307,000 | 307,000 | ||
| 2024-07-08 | Exton Michael Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,675,000 | 1,675,000 | ||
| 2024-05-13 | Swain Judith L Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 | ||
| 2024-05-13 | Swain Judith L Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-13 | Sullivan Diane E. Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 | ||
| 2024-05-13 | Sullivan Diane E. Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-13 | SOBECKI CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 | ||
| 2024-05-13 | SOBECKI CHRISTOPHER J Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-13 | LEFKOWITZ ROBERT J MD Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 | ||
| 2024-05-13 | LEFKOWITZ ROBERT J MD Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-13 | DEBBANE RAYMOND Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 | ||
| 2024-05-13 | DEBBANE RAYMOND Director | Grant or award · Restricted Stock Units | +36,810 | 36,810 | ||
| 2024-05-13 | BARKER SAM L Director | Grant or award · Stock Option (Right to Buy) | +44,906 | 44,906 |
Page 10 of 15 · 285 trades